Back to search
FDAFDA · Food and drugs·Recall number D-1508-2014

Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/25 mg, 30 and 90 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-107-30 and NDC 65597-107-90

Published August 6, 2014 · Recall initiated: July 12, 2014

Summary

FDA records drug Class II recall D-1508-2014, published August 6, 2014 and initiated July 12, 2014. Recalling firm: Daiichi Sankyo Pharma Development; Status: Terminated; Lot: 30 count/Lot #0002108 Exp - 12/31/2016; 90 count/Lot #0002078 Exp - 12/31/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Daiichi Sankyo Pharma Development
Distributor
Nationwide
Lot
30 count/Lot #0002108 Exp - 12/31/2016; 90 count/Lot #0002078 Exp - 12/31/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/25 mg, 30 and 90 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-107-30 and NDC 65597-107-90 recalled?

Yes. FDA published recall D-1508-2014 on August 6, 2014. Reported hazard: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone